Document ID: chunk:federal_register_of_legislation:F2024N01140:schedule:2
Version: federal_register_of_legislation:F2024N01140
Segment Type: schedule
Provision Reference: sch 2
Character Range: 4193–4781

Schedule 2—Amendments commencing immediately after the commencement of Schedule 3 to the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 4) 2024

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023

  1  Section 5 (table)
Omit:
Atropine Injection (Pfizer)  Atropine  Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL  Injection

Substitute:
Atropine Injection (Bridgewest)  Atropine  Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL  Injection